Publication:
Healthy lifestyle, metabolomics and incident type 2 diabetes in a population-based cohort from Spain

dc.contributor.authorDelgado-Velandia, Mario
dc.contributor.authorGonzález-Marrachelli, Vannina
dc.contributor.authorDomingo-Relloso, Arce
dc.contributor.authorGalvez-Fernandez, Marta
dc.contributor.authorGrau-Perez, Maria
dc.contributor.authorOlmedo, Pablo
dc.contributor.authorGalan, Iñaki
dc.contributor.authorRodríguez-Artalejo, Fernando
dc.contributor.authorAmigo, Nuria
dc.contributor.authorBriongos-Figuero, Laisa
dc.contributor.authorRedon, Josep
dc.contributor.authorMartin-Escudero, Juan Carlos
dc.contributor.authorMonleon-Salvado, Daniel
dc.contributor.authorTellez-Plaza, Maria
dc.contributor.authorSotos-Prieto, Mercedes
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderGeneralitat Valenciana (España)
dc.contributor.funderJunta de Castilla y León (España)
dc.contributor.funderCentro de Investigación Biomédica en Red - CIBERONC (Cáncer)
dc.contributor.funderMinisterio de Ciencia y Universidades (España)
dc.contributor.funderFundación La Caixa
dc.contributor.funderUnión Europea. Fondo Social Europeo (ESF/FSE)
dc.contributor.funderMinisterio de Ciencia e Innovación (España)
dc.contributor.funderPlan Nacional de I+D+i (España)
dc.contributor.funderAutonomous University of Madrid (España)
dc.date.accessioned2022-05-20T09:02:44Z
dc.date.available2022-05-20T09:02:44Z
dc.date.issued2022-01-27
dc.description.abstractBackground: The contribution of metabolomic factors to the association of healthy lifestyle with type 2 diabetes risk is unknown. We assessed the association of a composite measure of lifestyle with plasma metabolite profiles and incident type 2 diabetes, and whether relevant metabolites can explain the prospective association between healthy lifestyle and incident type 2 diabetes. Methods: A Healthy Lifestyle Score (HLS) (5-point scale including diet, physical activity, smoking status, alcohol consumption and BMI) was estimated in 1016 Hortega Study participants, who had targeted plasma metabolomic determinations at baseline examination in 2001-2003, and were followed-up to 2015 to ascertain incident type 2 diabetes. Results: The HLS was cross-sectionally associated with 32 (out of 49) plasma metabolites (2.5% false discovery rate). In the subset of 830 participants without prevalent type 2 diabetes, the rate ratio (RR) and rate difference (RD) of incident type 2 diabetes (n cases = 51) per one-point increase in HLS was, respectively, 0.69 (95% CI, 0.51, 0.93), and - 8.23 (95% CI, - 16.34, - 0.13)/10,000 person-years. In single-metabolite models, most of the HLS-related metabolites were prospectively associated with incident type 2 diabetes. In probit Bayesian Kernel Machine Regression, these prospective associations were mostly driven by medium HDL particle concentration and phenylpropionate, followed by small LDL particle concentration, which jointly accounted for ~ 50% of the HLS-related decrease in incident type 2 diabetes. Conclusions: The HLS showed a strong inverse association with incident type 2 diabetes, which was largely explained by plasma metabolites measured years before the clinical diagnosis.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis work was supported by the Strategic Action for Research in Health sciences [PI10/0082, PI13/01848, PI14/00874, PI16/01402, PI11/00726, PI16/609, PI16/1512, PI18/287, PI19/319 and PI20/00896], the GUTMOM Project (JPI-A Healthy Diet for a Healthy Life INTIMIC-085, State Secretary of R + D + I PCIN-2017-117), the Cátedra de Epidemiología y Control del Riesgo Cardiovascular at UAM (#820024), the State Agency for Research (PID2019-108973RB-C21 and C22), the Valencia Government (GRUPOS 03/101; PROMETEO/2009/029 and ACOMP/2013/039), the Castilla-Leon Government (GRS/279/A/08) and European Network of Excellence Ingenious Hypercare (EPSS- 037093) from the European Commission; CIBER Fisiopatología Obesidad y Nutrición (CIBEROBN) (CIBER-02-08-2009, CB06/03 and CB12/03/30016). MSP holds a Ramón y Cajal contract (RYC-2018-025069-I) from the Ministry of Science, Innovation and Universities. MDV holds a “Predoctoral Training in Health Research” contract (FI20/00162) from the Carlos III Health Institute. MGP and ADR received the support of a fellowship from “la Caixa” Foundation (ID 100010434, fellowship codes LCF/BQ/IN18/11660001, and LCF/BQ/DR19/11740016, respectively). PO received the support of a Sara Borrell contract from the Carlos III Health Institute (reference CD16/00255). The Strategic Action for Research in Health Sciences, CIBEROBN are initiatives from Carlos III Health Institute Madrid and co-funded by the European Social Fund “The ESF - investing in your future”. The State Agency for Research and Carlos III Health Institute belong to the Spanish Ministry of Science and Innovation. The funding bodies had no role in the study design, data collection and analysis, interpretation of results, manuscript preparation or in the decision to submit this manuscript for publication.es_ES
dc.format.number1es_ES
dc.format.page8es_ES
dc.format.volume19es_ES
dc.identifier.citationInt J Behav Nutr Phys Act. 2022 Jan 27;19(1):8.es_ES
dc.identifier.doi10.1186/s12966-021-01219-3es_ES
dc.identifier.e-issn1479-5868es_ES
dc.identifier.journalThe International Journal of Behavioral Nutrition and Physical Activityes_ES
dc.identifier.pubmedID35086546es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/14431
dc.language.isoenges_ES
dc.publisherBioMed Central (BMC)
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PID2019-108973RB-C22es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/RYC-2018-025069-Ies_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PID2019-108973RB-C21es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MINECO//CB12%2F03%2F30016/ES/INCORPORACION GRUPOS CIBER FISIOPATOLOGIA DE LA OBESIDAD Y NUTRICION (CIBER OBN)/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/CB06/03es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/CIBER-02-08-2009es_ES
dc.relation.projectFISinfo:fis/Instituto de Salud Carlos III/null/null/Subprograma de proyectos de investigacion en salud (AES 2013) (2013)/PI13/01848es_ES
dc.relation.projectFISinfo:fis/Instituto de Salud Carlos III/null/null/Subprograma de proyectos de investigacion en salud (AES 2014). Modalidad proyectos en salud. (2014)/PI14/00874es_ES
dc.relation.projectFISinfo:fis/Instituto de Salud Carlos III/Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia/Subprograma Estatal de Generación de Conocimiento/Proyectos de investigacion en salud (AES 2016). Modalidad proyectos en salud. (2016)/PI16/01402es_ES
dc.relation.projectFISinfo:fis/Instituto de Salud Carlos III/Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I/Subprograma Estatal de Generación de Conocimiento/PI20 - Proyectos de investigacion en salud (AES 2020). Modalidad proyectos de investigación en salud. (2020)/PI20/00896es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/PI10/0082es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/PI11/00726es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/PI16/609es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/PI16/1512es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/PI18/287es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/PI19/319es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/FI20/00162es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/CD16/00255es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/EPSS-037093es_ES
dc.relation.publisherversionhttps://doi.org/10.1186/s12966-021-01219-3es_ES
dc.repisalud.centroISCIII::Centro Nacional de Epidemiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectCohort studyes_ES
dc.subjectHealthy lifestylees_ES
dc.subjectMetabolomicses_ES
dc.subjectSpanish populationes_ES
dc.subjectType 2 diabeteses_ES
dc.titleHealthy lifestyle, metabolomics and incident type 2 diabetes in a population-based cohort from Spaines_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationba040db6-76e4-4a6d-a8c8-61d3e3913579
relation.isAuthorOfPublication6468a0e9-321f-45d5-b9e1-b5b6e753956f
relation.isAuthorOfPublication6834f05e-f02e-4189-accb-bd7b86298721
relation.isAuthorOfPublication0ff1ae79-727d-45dc-809f-c6dc87c2b66a
relation.isAuthorOfPublication429a9626-da12-4fcc-83f2-f24dafa525ec
relation.isAuthorOfPublication.latestForDiscoveryba040db6-76e4-4a6d-a8c8-61d3e3913579
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublication842e6617-7822-4501-a927-7e8cedda4aa6
relation.isFunderOfPublicationd1a8e7e7-3324-4d09-b435-4b96717a7edf
relation.isFunderOfPublicationf51ae40b-c03a-4bce-b62a-9d2313eed126
relation.isFunderOfPublication6544a51b-1e06-4f2b-a7ec-42488cd60223
relation.isFunderOfPublicationf04d23ec-a91d-4242-88b0-cc436888f8a2
relation.isFunderOfPublication36ca2ebf-c6c3-4f53-8618-500af224a277
relation.isFunderOfPublication289dce42-6a28-4892-b0a8-c70c46cbb185
relation.isFunderOfPublication0e5401ef-8ce7-439f-85e0-4e3550b5fade
relation.isFunderOfPublication8bc8ad48-47a0-4050-95e3-9f24d7235fab
relation.isFunderOfPublication.latestForDiscovery7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isPublisherOfPublication4fe896aa-347b-437b-a45b-95f4b60d9fd3
relation.isPublisherOfPublication.latestForDiscovery4fe896aa-347b-437b-a45b-95f4b60d9fd3

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
HealthyLifestyleMetabolomicsIncident_2022.pdf
Size:
959.16 KB
Format:
Adobe Portable Document Format
Description:
Artículo principal
Loading...
Thumbnail Image
Name:
HealthyLifestyleMetabolomicsIncident11SupplementaryInformation_2022.pdf
Size:
936.13 KB
Format:
Adobe Portable Document Format
Description:
Supplementary Information